These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 2818142

  • 1. Depression in panic disorder and response to alprazolam therapy.
    Pyke RE.
    Arch Gen Psychiatry; 1989 Nov; 46(11):1053-4. PubMed ID: 2818142
    [No Abstract] [Full Text] [Related]

  • 2. Alprazolam in the treatment of panic attack patients with and without major depression.
    Pyke RE, Kraus M.
    J Clin Psychiatry; 1988 Feb; 49(2):66-8. PubMed ID: 3338978
    [Abstract] [Full Text] [Related]

  • 3. Secondary depression in panic disorder and agoraphobia. I. Frequency, severity, and response to treatment.
    Lesser IM, Rubin RT, Pecknold JC, Rifkin A, Swinson RP, Lydiard RB, Burrows GD, Noyes R, DuPont RL.
    Arch Gen Psychiatry; 1988 May; 45(5):437-43. PubMed ID: 3282480
    [Abstract] [Full Text] [Related]

  • 4. Subtyping panic disorder by major depression and avoidance behaviour and the response to active treatment.
    Maier W, Rosenberg R, Argyle N, Buller R, Roth M, Brandon S, Benkert O.
    Eur Arch Psychiatry Clin Neurosci; 1991 May; 241(1):22-30. PubMed ID: 1832302
    [Abstract] [Full Text] [Related]

  • 5. Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia.
    Klerman GL.
    J Psychiatr Res; 1990 May; 24 Suppl 2():27-41. PubMed ID: 1980697
    [Abstract] [Full Text] [Related]

  • 6. Combined alprazolam and phenelzine treatment of refractory depression with panic attacks.
    Deicken RF.
    Biol Psychiatry; 1987 Jun; 22(6):762-6. PubMed ID: 3593814
    [No Abstract] [Full Text] [Related]

  • 7. Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
    Taylor CB, Hayward C, King R, Ehlers A, Margraf J, Maddock R, Clark D, Roth WT, Agras WS.
    J Clin Psychopharmacol; 1990 Apr; 10(2):112-8. PubMed ID: 2187912
    [Abstract] [Full Text] [Related]

  • 8. Psychopharmacological treatment of panic disorder and related states: a placebo controlled study of alprazolam.
    Swinson RP, Pecknold JC, Kuch K.
    Prog Neuropsychopharmacol Biol Psychiatry; 1987 Apr; 11(2-3):105-13. PubMed ID: 3628823
    [Abstract] [Full Text] [Related]

  • 9. Secondary depression in panic disorder and agoraphobia. II. Dimensions of depressive symptomatology and their response to treatment.
    Lesser IM, Rubin RT, Rifkin A, Swinson RP, Ballenger JC, Burrows GD, Dupont RL, Noyes R, Pecknold JC.
    J Affect Disord; 1989 Apr; 16(1):49-58. PubMed ID: 2521651
    [Abstract] [Full Text] [Related]

  • 10. Clonazepam in the treatment of patients with recurrent panic attacks.
    Beaudry P, Fontaine R, Chouinard G, Annable L.
    J Clin Psychiatry; 1986 Feb; 47(2):83-5. PubMed ID: 3944069
    [Abstract] [Full Text] [Related]

  • 11. Placebo response in panic disorder.
    Coryell W, Noyes R.
    Am J Psychiatry; 1988 Sep; 145(9):1138-40. PubMed ID: 3046384
    [Abstract] [Full Text] [Related]

  • 12. Benzodiazepine treatment of panic disorder: a comparison of alprazolam and lorazepam.
    Charney DS, Woods SW.
    J Clin Psychiatry; 1989 Nov; 50(11):418-23. PubMed ID: 2808308
    [Abstract] [Full Text] [Related]

  • 13. Clinical and medication outcome after short-term alprazolam and behavioral group treatment in panic disorder. 2.5 year naturalistic follow-up study.
    Nagy LM, Krystal JH, Woods SW, Charney DS.
    Arch Gen Psychiatry; 1989 Nov; 46(11):993-9. PubMed ID: 2818144
    [Abstract] [Full Text] [Related]

  • 14. The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reports.
    Marks IM, De Albuquerque A, Cottraux J, Gentil V, Greist J, Hand I, Liberman RL, Relvas JS, Tobeña A, Tyrer P.
    Arch Gen Psychiatry; 1989 Jul; 46(7):668-72. PubMed ID: 2660772
    [No Abstract] [Full Text] [Related]

  • 15. Alprazolam in panic disorder: a retrospective analysis.
    Shelton RC, Harvey DS, Stewart PM, Loosen PT.
    Prog Neuropsychopharmacol Biol Psychiatry; 1993 May; 17(3):423-34. PubMed ID: 8475324
    [Abstract] [Full Text] [Related]

  • 16. Drug treatment of panic disorder: the comparative efficacy of imipramine, alprazolam, and trazodone.
    Charney DS, Woods SW, Goodman WK, Rifkin B, Kinch M, Aiken B, Quadrino LM, Heninger GR.
    J Clin Psychiatry; 1986 Dec; 47(12):580-6. PubMed ID: 3536889
    [Abstract] [Full Text] [Related]

  • 17. Emergence of depressive symptoms in patients receiving alprazolam for panic disorder.
    Lydiard RB, Laraia MT, Ballenger JC, Howell EF.
    Am J Psychiatry; 1987 May; 144(5):664-5. PubMed ID: 3578580
    [Abstract] [Full Text] [Related]

  • 18. Major depression in patients with agoraphobia and panic disorder.
    Breier A, Charney DS, Heninger GR.
    Arch Gen Psychiatry; 1984 Dec; 41(12):1129-35. PubMed ID: 6508503
    [Abstract] [Full Text] [Related]

  • 19. Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment.
    Deltito JA, Argyle N, Klerman GL.
    J Clin Psychiatry; 1991 Mar; 52(3):121-7. PubMed ID: 2005075
    [Abstract] [Full Text] [Related]

  • 20. Alprazolam treatment for panic disorders.
    Alexander PE, Alexander DD.
    J Clin Psychiatry; 1986 Jun; 47(6):301-4. PubMed ID: 2872205
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.